Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220551) titled 'A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants' on Oct. 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: UCB Biopharma SRL

Condition: Healthy Volunteers

Intervention: Drug: UCB0022

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 22, 2025

Target Sample Size: 14

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07220551

Disclaimer: Curated by HT Synd...